Vanguard Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $71.8M | Buy |
|
|||||
|
2023
Q4 | $71M | Buy |
|
|||||
|
2023
Q3 | $55.6M | Sell |
|
|||||
|
2023
Q2 | $61.8M | Sell |
|
|||||
|
2023
Q1 | $71.2M | Sell |
|
|||||
|
2022
Q4 | $77.8M | Sell |
|
|||||
|
2022
Q3 | $88.7M | Buy |
|
|||||
|
2022
Q2 | $57.8M | Buy |
|
|||||
|
2022
Q1 | $33.3M | Buy |
|
|||||
|
2021
Q4 | $33.9M | Sell |
|
|||||
|
2021
Q3 | $134M | Buy |
|
|||||
|
2021
Q2 | $144M | Sell |
|
|||||
|
2021
Q1 | $177M | Buy |
|
|||||
|
2020
Q4 | $219M | Buy |
|
|||||
|
2020
Q3 | $194M | Buy |
|
|||||
|
2020
Q2 | $212M | Buy |
|
|||||
|
2020
Q1 | $104M | Buy |
|
|||||
|
2019
Q4 | $137M | Buy |
|
|||||
|
2019
Q3 | $49M | Buy |
|
|||||
|
2019
Q2 | $17.9M | Buy |
|
|||||
|
2019
Q1 | $17.9M | Buy |
|
|||||
|
2018
Q4 | $15M | Buy |
|
|||||
|
2018
Q3 | $26.2M | Buy |
|
|||||
|
2018
Q2 | $26M | Buy |
|
|||||
|
2018
Q1 | $6.53M | Buy |
|
|||||
|
2017
Q4 | $6.59M | Buy |
|
|||||
|
2017
Q3 | $3.46M | Buy |
|